Fenghua Wang

6PUBLICATIONS
44CO-AUTHORS
Cancer geneticsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 31, 2023
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023.

Feng-Hua Wang, Xiao-Tian Zhang, Lei Tang

|Jul 12, 2023
Glutamine metabolic microenvironment drives M2 macrophage polarization to mediate trastuzumab resistance in HER2-positive gastric cancer.

Xingbin Hu, Zhenfeng Ma, Beibei Xu

|Nov 18, 2022
Safety and Clinical Activity of SHR7390 Monotherapy or Combined With Camrelizumab for Advanced Solid Tumor: Results From Two Phase I Trials.

Xiao-Li Wei, Yang Zhang, Hong-Yun Zhao

|Aug 05, 2022
A Randomized, Open-Label, Multicenter, Phase 3 Study of High-Dose Vitamin C Plus FOLFOX ± Bevacizumab versus FOLFOX ± Bevacizumab in Unresectable Untreated Metastatic Colorectal Cancer (VITALITY Study).

Feng Wang, Ming-Ming He, Jian Xiao

|Dec 20, 2021
Elevated peripheral blood neutrophil-to-lymphocyte ratio is associated with an immunosuppressive tumour microenvironment and decreased benefit of PD-1 antibody in advanced gastric cancer.

Dan-Yun Ruan, Yan-Xing Chen, Xiao-Li Wei

|Jul 06, 2017
The Ratio of C-Reactive Protein/Albumin is a Novel Inflammatory Predictor of Overall Survival in Cisplatin-Based Treated Patients with Metastatic Nasopharyngeal Carcinoma.

Peng Sun, Cui Chen, Yi Xia

Pageof 1

Frequent Collaborators

4 joint publications

Rui-Hua Xu

2 joint publications

Jie-Er Ying

1 joint publications

Feng Wang

1 joint publications

Ming-Ming He